PharmaTelevision - BioBay: Using support to bring innovation home

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BioBay: Using support to bring innovation home

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this interview filmed at BioPharm America, Dr Fintan Walton talks to Yuwen Liu, General Manager of BioBay, China about BioBay’s mission to attract and encourage biotech in the region.

They discuss:

• why the initiative took place and what it’s about
• government investment in innovation
• the 134 companies already based in Suzhou
• sources of investment in BioBay companies
• how BioBay fully supports companies new to the region and facilitates companies’ moves with free advice
• BioBay’s aims for the future – to attract more companies to this fastest growing life sciences park in China and to continue to build the community/cluster

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Why the initiative took place and what it's about.

Fintan Walton:

Hello and welcome to PharmaTelevision News review here in San Francisco at BioPharm America. On this show I have Yuwen Liu, who is CEO of BioBay which is based in China, welcome to the show.

Yuwen Liu:

Thank you.

Fintan Walton:

BioBay is a initiative by the local government?

Yuwen Liu:

Yes.

Fintan Walton:

In just North of Shanghai in a region called Suzhou?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Yuwen Liu

General Manager

Yuwen Liu graduated from China Pharmaceutical University with an Ms in Pharmaceutics and MBA at Fudan University, China and Norwegian Management School, and is a licensed pharmacist. She started her career with Capsugel, a division of Pfizer in Suzhou, China as a quality engineer in 1997 and was promoted to be QA manager in April 1998. In May 2000, following strategic expansion of CapsugelChina, she transferred to New Business Development department managing new product market opportunity exploration in great China region. In May 2003, she moved to Shanghai as General Manager to set up the representative office for Perrigo Company (the world's largest manufacturer of OTC pharmaceutical and nutritional products for the store brand market) and is taking charge of all related market development activities including JV's in China as well as supply management in other Asia Pacific regions such as Japan, Korea, Taiwan etc. In Dec. 2005, she moved back to Suzhou as executive vice president for BioBay, a bio science park funded by Suzhou Industrial Park, whose mission is to build an integrated comprehensive platform for biotech, pharmaceutical and nanotech research and development in China. August, 2007, she became the general manager of BioBay, vice president of Suzhou Ventures Group, assistance director of Suzhou Industrial Park Science & Technology Bureau.

BioBay

BioBay, is an inclusive park and welcomes biotech companies, R&D enterprises, and professionals throughout the world. Its goal is to encourage and support the development of a modern bio and nanotech industry in Suzhou.